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TMedtronic-CoreValve device was utilized in 195 (71%) and the Edwards-Sapien
device in 80 (29%) of patients. The trans-femoral, trans-axillar, trans-apical, trans-
aortic and retroperitoneal route were used in 224, 20, 29, 1 and 1 patients; respec-
tively. Procedural success was 97.1%. One month, 1 year, 2 and 3 years survival rates
were 97%, 91%, 85% and 70%; respectively. Two patients (0.7%) needed urgent car-
diac surgery due to pericardial tamponade. Peri-procedural\in-hospital stroke was
diagnosed in 9 (3.2%) patients. Permanent pacemaker was required in 40 (14.5%)
patients: (36 cases in CoreValve and 4 in Sapien valves). Signiﬁcant paravalvular leak
(moderate) was noted in 22 (8%) patients. After the procedure, mean valve gradients
decreased from 51.216 to 8.17 (p<0.001). Symptomatic improvement was evident
during follow up, having 98% of patients in NYHA-FC I or II.
CONCLUSION The current report signiﬁes that catheter-based treatment of mostly
elderly patients with severe aortic stenosis is feasible, safe and associated with
satisfactory long-term outcomes. This approach has proved itself in ’real life’ of TAVI
practice as shown by the reported results.CRT-806
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BACKGROUND Obese aortic stenosis patients undergoing surgical replacement have
improved survival in comparison with underweight patients. Currently there are
scarce data regarding BMI impact on outcome of severe aortic stenosis patients un-
dergoing transcatheter aortic valve replacement (TAVR).
OBJECTIVE Our aim was to assess the impact of BMI on mortality and complications
rate of TAVR patients.
METHODS Patient population included all severe AS patients undergoing TAVR at our
institution, between May 2007 and July 2014. Baseline demographic, clinical and
imaging parameters were compared between 3 patients groups according to BMI
(<20, 20-30 and >30), peri-procedural complications rate were assessed and mortality
was evaluated by the BMI group.
RESULTS Among 340 severe AS patients undergoing TAVR, 9% (n¼29) were under-
weight with a BMI<20, 64% (n¼219) had a BMI of 20-30, and 27% (n¼29) were obese
with BMI >30.
Patients with BMI 20-30 were older and had higher proportion of men in compar-
ison with under- and overweight patients (857 vs. 8118 and 808, p<0.001 and 61
vs. 28 and 35%, p<0.001). Diabetes Mellitus was more prevalent as BMI increased,
while the STS score was inversely related to BMI (125%, 94% and 94%, for the
underweight, normal weight and obese respectively, p¼0.004). Survival comparison
has showed increased mortality rates among underweight patients, but no signiﬁcant
difference was noted between the normal and obese patients (graph).CONCLUSION Underweight severe aortic stenosis patients undergoing TAVR have
increased risk for long term mortality in comparison with normal weight or obese
patients, however obesity doesn’t seem to portend signiﬁcantly higher survival rates
when compared with normal weight TAVR patients.CRT-807
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BACKGROUND Previous studies have demonstrated reduced survival in high risk
patients with symptomatic AS undergoing TAVR who had elevated pulmonary artery
systolic pressure (PASP) at baseline. However, effects of elevated intra-operative
PASP on long term outcomes in these patients are not clearly deﬁned.
METHODS We retrospectively evaluated 100 consecutive patients undergoing TAVR
at our institution between 2012 and 2013. Baseline characteristics, 30 day major
adverse cardiovascular events (MACE), deﬁned as composite end point of stroke,
myocardial infarction, cardiovascular death or re-hospitalization, and 1 year all-cause
mortality stratiﬁed by intra-operative PASP were analyzed.
RESULTS On cox regression survival analysis in patients undergoing TAVR, being
in the highest tertile of intra-operative PASP was an independent predictor of a
higher 30 day MACE event rate (HR: 4.1, 95% CI: 1.8 to 9.2, p ¼ 0.001) and long
term mortality at 12 month (hazard ratio (HR): 6.6, 95% conﬁdence interval (CI):
3.8 to 11.4, p < 0.001). Following TAVR, patients with greater than 10mmHg
reduction in their intra-operative PASP, had improved long term survival at 12
months (HR: 0.14, 95% CI: 0.04 to 0.46, p ¼ 0.001). In addition, an increase of
greater than 5% in left ventricular (LV) ejection fraction (EF) after TAVR was also
associated with improved long-term survival at 12 months (HR: 0.23, 95% CI: 0.07
to 0.78, p ¼ 0.02).
CONCLUSION In high risk patients with severe aortic stenosis, elevated pulmonary
artery systolic pressures during trans-catheter aortic valve replacement was associ-
ated with reduced survival at 1 year. Reduction in PASP after TAVR was one of the
strongest predictor of survival in our patient population. More large scale randomized
studies are needed to further evaluate these results.
